Zydus Lifesciences Limited
ZYDUSLIFE
Clasificación en acciones
#1755
Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952,... Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952, operates globally in the pharmaceutical and consumer goods sectors. Renamed from Cadila Healthcare Limited in February 2022, the company manages the entire lifecycle of pharmaceutical products, from research and development to manufacturing, marketing, and distribution. Its extensive reach covers India, the United States, Europe, Latin America, the Asia Pacific region, and Africa. The company's pharmaceutical division provides a broad spectrum of offerings, including finished dosage human formulations (such as generics, branded generics, and specialized treatments like biosimilars and vaccines), as well as active pharmaceutical ingredients (APIs). Zydus focuses on therapeutic areas like pain management, neurology, dermatology, and liver diseases, among others. Additionally, it is developing a pipeline of biological products aimed at conditions such as oncology, autoimmune disorders, nephrology, ophthalmology, inflammation, rheumatology, hepatology, and infectious diseases. In its consumer products segment, Zydus offers popular wellness brands including Complan, the EverYuth range of skincare products, Nycil, Glucon-D glucose powder, Nutralite, and the Nutralite Doodhshakti dairy product line. Beyond these core operations, the company is also involved in investment activities, animal health and veterinary services, pharmacy retail, and human resource supply and administration.
Precio por acción
$12.29
Última sincronización: 2026-10-19
Capitalización bursátil
$12.26B
Cambio (1 día)
-1.01%
Cambio (1 año)
7.78%
País
IN
Comercio Zydus Lifesciences Limited (ZYDUSLIFE)
Categoría
Healthcare
Margen Operativo de Zydus Lifesciences Limited (ZYDUSLIFE)
Margen Operativo al October 2026 TTM: 18.58%
Según los informes financieros más recientes y el precio de las acciones de Zydus Lifesciences Limited, el margen operativo actual (TTM) es 18.58%. Al final de 2024, el margen operativo era 38.86%.
Historial de Margen Operativo de Zydus Lifesciences Limited desde 2004 hasta 2026
Margen Operativo al final de cada año
| Año | Margen Operativo | Cambiar |
|---|---|---|
| 2026 (TTM) | 18.58% | -55.03% |
| 2025 | 41.32% | 6.33% |
| 2024 | 38.86% | 143.64% |
| 2023 | 15.95% | -2.51% |
| 2022 | 16.36% | -11.09% |
| 2021 | 18.40% | 20.89% |
| 2020 | 15.22% | -18.91% |
| 2019 | 18.77% | -5.35% |
| 2018 | 19.83% | 21.73% |
| 2017 | 16.29% | -23.12% |
| 2016 | 21.19% | 23.13% |
| 2015 | 17.21% | 23.02% |
| 2014 | 13.99% | -6.48% |
| 2013 | 14.96% | 26.35% |
| 2012 | 11.84% | -42.07% |
| 2011 | 20.44% | 9.13% |
| 2010 | 18.73% | 4.23% |
| 2009 | 17.97% | 11.96% |
| 2008 | 16.05% | -3.25% |
| 2007 | 16.59% | -22.59% |
| 2006 | 21.43% | 41.83% |
| 2005 | 15.11% | -2.33% |
| 2004 | 15.47% | 0.00% |
Margen Operativo de empresas similares o competidoras
| Empresa | Margen Operativo | Diferencia de Margen Operativo | País |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -98.77% |
IN
|
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.